| Hepatocellular Carcinoma |
1 |
0.94 |
| Transplantation |
0 |
0.79 |
| Transplant Program |
0 |
0.59 |
| Liver |
0 |
0.44 |
| Biliary Disease |
0 |
0.41 |
| Cancer |
0 |
0.4 |
| Liver Disease |
0 |
0.34 |
| Radiation Therapy |
0 |
0.32 |
| End-Stage Liver Disease |
0 |
0.3 |
| Diagnostic Liver Biopsy |
0 |
0.28 |
| Liver Biopsy |
0 |
0.28 |
| Model for End-Stage Liver Disease |
0 |
0.28 |
| Liquid Biopsy |
0 |
0.22 |
| Ablation |
0 |
0.16 |
| External Beam Radiotherapy (EBRT) |
0 |
0.14 |
| Radiofrequency Ablation (RFA) |
0 |
0.14 |
| Cirrhosis |
0 |
0.08 |
| Biopsy |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Health Care Facilities, Manpower, and Services |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Nonprofit Organizations |
0 |
0.04 |
| Oregon |
0 |
0.04 |
| Radiation Dose |
0 |
0.04 |
| Residency |
0 |
0.04 |
| Tumor |
0 |
0.04 |
| Waiting List |
0 |
0.04 |
| Washington |
0 |
0.04 |